News for Atara Biotherapeutics Stock (ATRA)
After Plunging 65.7% in 4 Weeks, Here's Why the Trend Might Reverse for Atara Biotherapeutics (ATRA)
Zacks Investment Research •
The Motley Fool •
Zacks Investment Research •
Analysts Estimate Atara Biotherapeutics (ATRA) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research •
Business Wire •